nach oben

Journal of Clinical Immunology

Erschienen in:

01.07.2014

Molecules Involved in the Crosstalk Between Immune- and Peripheral Nerve Schwann Cells

verfasst von: Nevena Tzekova, André Heinen, Patrick Küry

Erschienen in: Journal of Clinical Immunology | Sonderheft 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Schwann cells are the myelinating glial cells of the peripheral nervous system and establish myelin sheaths on large caliber axons in order to accelerate their electrical signal propagation. Apart from this well described function, these cells revealed to exhibit a high degree of differentiation plasticity as they were shown to re- and dedifferentiate upon injury and disease as well as to actively participate in regenerative- and inflammatory processes. This review focuses on the crosstalk between glial- and immune cells observed in many peripheral nerve pathologies and summarizes functional evidences of molecules, regulators and factors involved in this process. We summarize data on Schwann cell’s role presenting antigens, on interactions with the complement system, on Schwann cell surface molecules/receptors and on secreted factors involved in immune cell interactions or para-/autocrine signaling events, thus strengthening the view for a broader (patho) physiological role of this cell lineage.

Scherer SS, Arroyo EJ. Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst. 2002;7(1):1–12.PubMed

Son YJ, Thompson WJ. Schwann cell processes guide regeneration of peripheral axons. Neuron. 1995;14(1):125–32.PubMed

Martini R, Fischer S, Lopez-Vales R, David S. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia. 2008;56(14):1566–77.PubMed

Hoke A. Mechanisms of Disease: what factors limit the success of peripheral nerve regeneration in humans? Nat Clin Pract Neurol. 2006;2(8):448–54.PubMed

Gordon T. The role of neurotrophic factors in nerve regeneration. Neurosurg Focus. 2009;26(2):E3.PubMed

Gordon T. Neurotrophic factor expression in denervated motor and sensory Schwann cells: Relevance to specificity of peripheral nerve regeneration. Exp Neurol. 2014;254C:99–108.

Armati PJ, Mathey EK. An update on Schwann cell biology–immunomodulation, neural regulation and other surprises. J Neurol Sci. 2013;333(1–2):68–72.PubMed

Bosse F, Hasenpusch-Theil K, Kury P, Muller HW. Gene expression profiling reveals that peripheral nerve regeneration is a consequence of both novel injury-dependent and reactivated developmental processes. J Neurochem. 2006;96(5):1441–57.PubMed

Arthur-Farraj PJ, Latouche M, Wilton DK, Quintes S, Chabrol E, Banerjee A, et al. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron. 2012;75(4):633–47.PubMedCentralPubMed

10.

Heinen A, Kremer D, Gottle P, Kruse F, Hasse B, Lehmann H, et al. The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. Proc Natl Acad Sci U S A. 2008;105(25):8748–53.PubMedCentralPubMed

11.

Heinen A, Lehmann HC, Küry P. Negative regulators of schwann cell differentiation-novel targets for peripheral nerve therapies? J Clin Immunol. 2013;33 Suppl 1:S18–26. Epub 2012/09/08.PubMed

12.

Meyer Zu Horste G, Hu W, Hartung HP, Lehmann HC, Kieseier BC. The immunocompetence of Schwann cells. Muscle Nerve. 2008;37(1):3–13.PubMed

13.

Ydens E, Lornet G, Smits V, Goethals S, Timmerman V, Janssens S. The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis. 2013;55:95–103.PubMed

14.

Armati PJ, Pollard JD, Gatenby P. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve. 1990;13(2):106–16.PubMed

15.

Samuel NM, Jessen KR, Grange JM, Mirsky R. Gamma interferon, but not Mycobacterium leprae, induces major histocompatibility class II antigens on cultured rat Schwann cells. J Neurocytol. 1987;16(2):281–7.PubMed

16.

Kingston AE, Bergsteinsdottir K, Jessen KR, Van der Meide PH, Colston MJ, Mirsky R. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Eur J Immunol. 1989;19(1):177–83.PubMed

17.

Bergsteinsdottir K, Kingston A, Jessen KR. Rat Schwann cells can be induced to express major histocompatibility complex class II molecules in vivo. J Neurocytol. 1992;21(5):382–90.PubMed

18.

Lilje O, Armati PJ. The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro. J Neuroimmunol. 1997;77(1):75–84.PubMed

19.

Tsuyuki Y, Fujimaki H, Hikawa N, Fujita K, Nagata T, Minami M. IFN-gamma induces coordinate expression of MHC class I-mediated antigen presentation machinery molecules in adult mouse Schwann cells. Neuroreport. 1998;9(9):2071–5.PubMed

20.

Spierings E, de Boer T, Wieles B, Adams LB, Marani E, Ottenhoff TH. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy. J Immunol. 2001;166(10):5883–8.PubMed

21.

Lilje O. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol Life Sci. 2002;59(12):2191–8.PubMed

22.

Wekerle H, Schwab M, Linington C, Meyermann R. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol. 1986;16(12):1551–7.PubMed

23.

Meyer Zu Horste G, Heidenreich H, Mausberg AK, Lehmann HC, ten Asbroek AL, Saavedra JT, et al. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation. Neurobiol Dis. 2010;37(2):483–90.PubMed

24.

Meyer Zu Horste G, Heidenreich H, Lehmann HC, Ferrone S, Hartung HP, Wiendl H, et al. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies. Glia. 2010;58(1):80–92.PubMed

25.

Pollard JD, Baverstock J, McLeod JG. Class II antigen expression and inflammatory cells in the Guillain-Barre syndrome. Ann Neurol. 1987;21(4):337–41.PubMed

26.

Pollard JD, McCombe PA, Baverstock J, Gatenby PA, McLeod JG. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 1986;13(2):123–34.PubMed

27.

Mancardi GL, Cadoni A, Zicca A, Schenone A, Tabaton M, De Martini I, et al. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology. 1988;38(6):848–51.PubMed

28.

Mitchell GW, Williams GS, Bosch EP, Hart MN. Class II antigen expression in peripheral neuropathies. J Neurol Sci. 1991;102(2):170–6.PubMed

29.

Van Rhijn I, Van den Berg LH, Bosboom WM, Otten HG, Logtenberg T. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain J Neurol. 2000;123(Pt 10):2020–9.

30.

Im JS, Tapinos N, Chae GT, Illarionov PA, Besra GS, DeVries GH, et al. Expression of CD1d molecules by human schwann cells and potential interactions with immunoregulatory invariant NK T cells. J Immunol. 2006;177(8):5226–35.PubMed

31.

Wanschitz J, Maier H, Lassmann H, Budka H, Berger T. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome. Brain J Neurol. 2003;126(Pt 9):2034–42.

32.

Lee PR, Cohen JE, Fields RD. Immune system evasion by peripheral nerve sheath tumor. Neurosci Lett. 2006;397(1–2):126–9.PubMedCentralPubMed

33.

Reuss DE, Mucha J, Holtkamp N, Muller U, Berlien HP, Mautner VF, et al. Functional MHC class II is upregulated in neurofibromin-deficient Schwann cells. J Invest Dermatol. 2013;133(5):1372–5.PubMed

34.

Liu W, Ren Y, Bossert A, Wang X, Dayawansa S, Tong J, et al. Allotransplanted neurons used to repair peripheral nerve injury do not elicit overt immunogenicity. PLoS ONE. 2012;7(2):e31675.PubMedCentralPubMed

35.

Yang Y, Dai W, Chen Z, Yan Z, Yao Z, Zhang C. Downregulating immunogenicity of Schwann cells via inhibiting a potential target of class II transactivator (CIITA) gene. Bioscience Trends. 2013;7(1):50–5.PubMed

36.

Thams S, Brodin P, Plantman S, Saxelin R, Karre K, Cullheim S. Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction. J Neurosci Off J Soc Neurosci. 2009;29(43):13503–15.

37.

Murata K, Dalakas MC. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Brain J Neurol. 2000;123(Pt 8):1660–6.

38.

Kiefer R, Dangond F, Mueller M, Toyka KV, Hafler DA, Hartung HP. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Psychiatry. 2000;69(3):362–8.PubMedCentralPubMed

39.

Duan RS, Jin T, Yang X, Mix E, Adem A, Zhu J. Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells. Glia. 2007;55(7):772–6.PubMed

40.

Mao XJ, Zhang XM, Zhang HL, Quezada HC, Mix E, Yang X, et al. TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice. Neurosci Lett. 2010;470(1):19–23.PubMed

41.

Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11(5):373–84.PubMed

42.

Goethals S, Ydens E, Timmerman V, Janssens S. Toll-like receptor expression in the peripheral nerve. Glia. 2010;58(14):1701–9.PubMed

43.

Lee H, Park C, Cho IH, Kim HY, Jo EK, Lee S, et al. Double-stranded RNA induces iNOS gene expression in Schwann cells, sensory neuronal death, and peripheral nerve demyelination. Glia. 2007;55(7):712–22.PubMed

44.

Hao HN, Peduzzi-Nelson JD, VandeVord PJ, Barami K, DeSilva SP, Pelinkovic D, et al. Lipopolysaccharide-induced inflammatory cytokine production by Schwann's cells dependent upon TLR4 expression. J Neuroimmunol. 2009;212(1–2):26–34.PubMed

45.

Mietto BS, Jurgensen S, Alves L, Pecli C, Narciso MS, Assuncao-Miranda I, et al. Lack of galectin-3 speeds Wallerian degeneration by altering TLR and pro-inflammatory cytokine expressions in injured sciatic nerve. Eur J Neurosci. 2013;37(10):1682–90.PubMed

46.

Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, et al. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun. 2006;350(3):742–7.PubMed

47.

Mattos KA, Oliveira VG, D'Avila H, Rodrigues LS, Pinheiro RO, Sarno EN, et al. TLR6-driven lipid droplets in Mycobacterium leprae-infected Schwann cells: immunoinflammatory platforms associated with bacterial persistence. J Immunol. 2011;187(5):2548–58.PubMed

48.

Lisak RP, Bealmear B. Upregulation of intercellular adhesion molecule-1 (ICAM-1) on rat Schwann cells in vitro: comparison of interferon-gamma, tumor necrosis factor-alpha and interleukin-1. J Peripher Nerv Syst. 1997;2(3):233–43.PubMed

49.

Shen A, Yang J, Gu Y, Zhou D, Sun L, Qin Y, et al. Lipopolysaccharide-evoked activation of p38 and JNK leads to an increase in ICAM-1 expression in Schwann cells of sciatic nerves. FEBS J. 2008;275(17):4343–53.PubMed

50.

Kirsch M, Campos Friz M, Vougioukas VI, Hofmann HD. Wallerian degeneration and axonal regeneration after sciatic nerve crush are altered in ICAM-1-deficient mice. Cell Tissue Res. 2009;338(1):19–28.PubMed

51.

Chang CY, Lee YH, Jiang-Shieh YF, Chien HF, Pai MH, Chen HM, et al. Novel distribution of cluster of differentiation 200 adhesion molecule in glial cells of the peripheral nervous system of rats and its modulation after nerve injury. Neuroscience. 2011;183:32–46.PubMed

52.

Vedeler CA. Demonstration of Fc gamma receptors on human peripheral nerve fibres. J Neuroimmunol. 1987;15(2):207–16.PubMed

53.

Vedeler CA, Nilsen R, Matre R. Localization of Fc gamma receptors and complement receptors CR1 on human peripheral nerve fibres by immunoelectron microscopy. J Neuroimmunol. 1989;23(1):29–33.PubMed

54.

Vedeler CA, Scarpini E, Beretta S, Doronzo R, Matre R. The ontogenesis of Fc gamma receptors and complement receptors CR1 in human peripheral nerve. Acta Neuropathol. 1990;80(1):35–40.PubMed

55.

Vedeler CA, Fitzpatrick-Klove L. Receptors for immunoglobulin G demonstrated on human peripheral nerve fibres by electron microscopy. Neurosci Lett. 1990;115(2–3):167–70.PubMed

56.

Vedeler CA, Matre R, Kristoffersen EK, Ulvestad E. IgG Fc receptor heterogeneity in human peripheral nerves. Acta Neurol Scand. 1991;84(3):177–80.PubMed

57.

Vargas ME, Watanabe J, Singh SJ, Robinson WH, Barres BA. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc Natl Acad Sci U S A. 2010;107(26):11993–8.PubMedCentralPubMed

58.

Baetas-da-Cruz W, Alves L, Pessolani MC, Barbosa HS, Regnier-Vigouroux A, Corte-Real S, et al. Schwann cells express the macrophage mannose receptor and MHC class II. Do they have a role in antigen presentation? J Peripher Nerv Syst. 2009;14(2):84–92.PubMed

59.

Reichert F, Saada A, Rotshenker S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J Neurosci Off J Soc Neurosci. 1994;14(5 Pt 2):3231–45.

60.

Saada A, Reichert F, Rotshenker S. Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol. 1996;133(1):159–67.PubMed

61.

Teles RM, Krutzik SR, Ochoa MT, Oliveira RB, Sarno EN, Modlin RL. Interleukin-4 regulates the expression of CD209 and subsequent uptake of Mycobacterium leprae by Schwann cells in human leprosy. Infect Immun. 2010;78(11):4634–43.PubMedCentralPubMed

62.

Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J Neuroinflammation. 2011;8:24.PubMedCentralPubMed

63.

Stoll G, Schmidt B, Jander S, Toyka KV, Hartung HP. Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol. 1991;30(2):147–55.PubMed

64.

Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF. Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome. J Neurol Sci. 2000;174(1):16–21.PubMed

65.

Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, et al. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron. 2005;47(2):215–29.PubMed

66.

Lonigro A, Devaux JJ. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Brain J Neurol. 2009;132(Pt 1):260–73.

67.

Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol. 2005;58(2):203–10.PubMed

68.

Halstead SK, Humphreys PD, Zitman FM, Hamer J, Plomp JJ, Willison HJ. C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome. J Peripher Nerv Syst. 2008;13(3):228–35.PubMed

69.

Dailey AT, Avellino AM, Benthem L, Silver J, Kliot M. Complement depletion reduces macrophage infiltration and activation during Wallerian degeneration and axonal regeneration. J Neurosci Off J Soc Neurosci. 1998;18(17):6713–22.

70.

Ramaglia V, King RH, Nourallah M, Wolterman R, de Jonge R, Ramkema M, et al. The membrane attack complex of the complement system is essential for rapid Wallerian degeneration. J Neurosci Off J Soc Neurosci. 2007;27(29):7663–72. Epub 2007/07/20.

71.

Dashiell SM, Koski CL. Sublytic terminal complement complexes decrease P0 Gene expression in Schwann cells. J Neurochem. 1999;73(6):2321–30.PubMed

72.

David S, Hila S, Fosbrink M, Rus H, Koski CL. JNK1 activation mediates C5b-9-induced P0 mRNA instability and P0 gene expression in Schwann cells. J Peripher Nerv Syst. 2006;11(1):77–87.PubMed

73.

Dashiell SM, Rus H, Koski CL. Terminal complement complexes concomitantly stimulate proliferation and rescue of Schwann cells from apoptosis. Glia. 2000;30(2):187–98.PubMed

74.

Hila S, Soane L, Koski CL. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD. Glia. 2001;36(1):58–67.PubMed

75.

Dashiell SM, Vanguri P, Koski CL. Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells. Glia. 1997;20(4):308–21.PubMed

76.

de Jonge RR, Vreijling JP, Meintjes A, Kwa MS, van Kampen AH, van Schaik IN, et al. Transcriptional profile of the human peripheral nervous system by serial analysis of gene expression. Genomics. 2003;82(2):97–108.PubMed

77.

Funabashi K, Okada N, Matsuo S, Yamamoto T, Morgan BP, Okada H. Tissue distribution of complement regulatory membrane proteins in rats. Immunology. 1994;81(3):444–51.PubMedCentralPubMed

78.

Nose M, Katoh M, Okada N, Kyogoku M, Okada H. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology. 1990;70(2):145–9.PubMedCentralPubMed

79.

Sawant-Mane S, Piddlesden SJ, Morgan BP, Holers VM, Koski CL. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells. J Neuroimmunol. 1996;69(1–2):63–71.PubMed

80.

Koski CL, Estep AE, Sawant-Mane S, Shin ML, Highbarger L, Hansch GM. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins. J Neurochem. 1996;66(1):303–12.PubMed

81.

Vedeler CA, Conti G, Fujioka T, Scarpini E, Rostami A. The expression of CD59 in experimental allergic neuritis. J Neurol Sci. 1999;165(2):154–9.PubMed

82.

Vedeler CA, Matre R. Complement receptors CR1 on human peripheral nerve fibres. J Neuroimmunol. 1988;17(4):315–22.PubMed

83.

Vedeler CA, Conti G, Bannerman P, Pleasure D. Expression of genes encoding receptors for IgG (FcRIII) and for C3b/C4b (Crry) in rat sciatic nerve during development and Wallerian degeneration. J Neurosci Res. 1992;31(4):654–61.PubMed

84.

Vedeler CA, Matre R. Peripheral nerve CR1 limit complement-mediated haemolysis. J Neuroimmunol. 1990;30(1):95–8.PubMed

85.

Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, Gold R. Regulation of Fas and FasL expression on rat Schwann cells. Glia. 2000;30(4):373–81.PubMed

86.

Bonetti B, Valdo P, Ossi G, De Toni L, Masotto B, Marconi S, et al. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis. Glia. 2003;43(2):141–8.PubMed

87.

Eissner G, Kolch W, Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev. 2004;15(5):353–66.PubMed

88.

Thornhill PB, Cohn JB, Stanford WL, Desbarats J. The adaptor protein Grb2 regulates cell surface Fas ligand in Schwann cells. Biochem Biophys Res Commun. 2008;376(2):341–6.PubMed

89.

Mimouni-Rongy M, White JH, Weinstein DE, Desbarats J, Almazan G. Fas ligand acts as a counter-receptor in Schwann cells and induces the secretion of bioactive nerve growth factor. J Neuroimmunol. 2011;230(1–2):17–25.PubMed

90.

Dace DS, Khan AA, Stark JL, Kelly J, Cross AH, Apte RS. Interleukin-10 overexpression promotes Fas-ligand-dependent chronic macrophage-mediated demyelinating polyneuropathy. PLoS ONE. 2009;4(9):e7121.PubMedCentralPubMed

91.

Tang W, Lv Q, Chen XF, Zou JJ, Liu ZM, Shi YQ. CD8(+) T cell-mediated cytotoxicity toward Schwann cells promotes diabetic peripheral neuropathy. Cell Physiol Biochem Int J Exp Cell Phys Biochem Pharmacol. 2013;32(4):827–37.

92.

Mäurer M, Kobsar I, Berghoff M, Schmid CD, Carenini S, Martini R. Role of immune cells in animal models for inherited neuropathies: facts and visions. J Anat. 2002;200(4):405–14.PubMedCentralPubMed

93.

Carenini S, Mäurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, et al. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J Cell Biol. 2001;152(2):301–8.PubMedCentralPubMed

94.

Mäurer M, Muller M, Kobsar I, Leonhard C, Martini R, Kiefer R. Origin of pathogenic macrophages and endoneurial fibroblast-like cells in an animal model of inherited neuropathy. Mol Cell Neurosci. 2003;23(3):351–9.PubMed

95.

Fischer S, Kleinschnitz C, Muller M, Kobsar I, Ip CW, Rollins B, et al. Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy. Mol Cell Neurosci. 2008;37(2):359–66.PubMed

96.

Groh J, Weis J, Zieger H, Stanley ER, Heuer H, Martini R. Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X. Brain J Neurol. 2012;135(Pt 1):88–104.

97.

Horie H, Kadoya T, Hikawa N, Sango K, Inoue H, Takeshita K, et al. Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J Neurosci Off J Soc Neurosci. 2004;24(8):1873–80.

98.

Goncalves AF, Dias NG, Moransard M, Correia R, Pereira JA, Witke W, et al. Gelsolin is required for macrophage recruitment during remyelination of the peripheral nervous system. Glia. 2010;58(6):706–15.PubMed

99.

Ozaki A, Nagai A, Lee YB, Myong NH, Kim SU. Expression of cytokines and cytokine receptors in human Schwann cells. Neuroreport. 2008;19(1):31–5.PubMed

100.

Bergsteinsdottir K, Kingston A, Mirsky R, Jessen KR. Rat Schwann cells produce interleukin-1. J Neuroimmunol. 1991;34(1):15–23.PubMed

101.

Skundric DS, Bealmear B, Lisak RP. Induced upregulation of IL-1, IL-1RA and IL-1R type I gene expression by Schwann cells. J Neuroimmunol. 1997;74(1–2):9–18.PubMed

102.

Colomar A, Marty V, Medina C, Combe C, Parnet P, Amedee T. Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors. J Biol Chem. 2003;278(33):30732–40. Epub 2003/06/11.PubMed

103.

Skundric DS, Lisak RP, Rouhi M, Kieseier BC, Jung S, Hartung HP. Schwann cell-specific regulation of IL-1 and IL-1Ra during EAN: possible relevance for immune regulation at paranodal regions. J Neuroimmunol. 2001;116(1):74–82.PubMed

104.

Lisak RP, Bealmear B, Ragheb S. Interleukin-1 alpha, but not interleukin-1 beta, is a co-mitogen for neonatal rat Schwann cells in vitro and acts via interleukin-1 receptors. J Neuroimmunol. 1994;55(2):171–7.PubMed

105.

Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci Off J Soc Neurosci. 2002;22(8):3052–60.

106.

Murwani R, Armati P. Peripheral nerve fibroblasts as a source of IL-6, TNFalpha and IL-1 and their modulation by IFNgamma. J Neurol Sci. 1998;161(2):99–109.PubMed

107.

Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S. Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation. Pain. 2010;149(2):305–15.PubMed

108.

Guenard V, Dinarello CA, Weston PJ, Aebischer P. Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel. J Neurosci Res. 1991;29(3):396–400.PubMed

109.

Mey J, Schrage K, Wessels I, Vollpracht-Crijns I. Effects of inflammatory cytokines IL-1beta, IL-6, and TNFalpha on the intracellular localization of retinoid receptors in Schwann cells. Glia. 2007;55(2):152–64.PubMed

110.

Fontana X, Hristova M, Da Costa C, Patodia S, Thei L, Makwana M, et al. c-Jun in Schwann cells promotes axonal regeneration and motoneuron survival via paracrine signaling. J Cell Biol. 2012;198(1):127–41.PubMedCentralPubMed

111.

Zhelyaznik N, Mey J. Regulation of retinoic acid receptors alpha, beta and retinoid X receptor alpha after sciatic nerve injury. Neuroscience. 2006;141(4):1761–74.PubMed

112.

Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987;330(6149):658–9.PubMed

113.

Matsuoka I, Meyer M, Thoenen H. Cell-type-specific regulation of nerve growth factor (NGF) synthesis in non-neuronal cells: comparison of Schwann cells with other cell types. J Neurosci Off J Soc Neurosci. 1991;11(10):3165–77.

114.

Rutkowski JL, Tuite GF, Lincoln PM, Boyer PJ, Tennekoon GI, Kunkel SL. Signals for proinflammatory cytokine secretion by human Schwann cells. J Neuroimmunol. 1999;101(1):47–60.PubMed

115.

Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem. 1995;64(2):850–8.PubMed

116.

Grothe C, Heese K, Meisinger C, Wewetzer K, Kunz D, Cattini P, et al. Expression of interleukin-6 and its receptor in the sciatic nerve and cultured Schwann cells: relation to 18-kD fibroblast growth factor-2. Brain Res. 2000;885(2):172–81.PubMed

117.

Murwani R, Hodgkinson S, Armati P. Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation. J Neuroimmunol. 1996;71(1–2):65–71.PubMed

118.

Ramesh G, Santana-Gould L, Inglis FM, England JD, Philipp MT. The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root ganglia. J Neuroinflammation. 2013;10:88.PubMedCentralPubMed

119.

Lisak RP, Bealmear B. Antibodies to interleukin-6 inhibit Schwann cell proliferation induced by unfractionated cytokines. J Neuroimmunol. 1994;50(2):127–32. Epub 1994/03/01.PubMed

120.

Lara-Ramirez R, Segura-Anaya E, Martinez-Gomez A, Dent MA. Expression of interleukin-6 receptor alpha in normal and injured rat sciatic nerve. Neuroscience. 2008;152(3):601–8.PubMed

121.

Hirota H, Kiyama H, Kishimoto T, Taga T. Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med. 1996;183(6):2627–34.PubMed

122.

Haggiag S, Chebath J, Revel M. Induction of myelin gene expression in Schwann cell cultures by an interleukin-6 receptor-interleukin-6 chimera. FEBS Lett. 1999;457(2):200–4.PubMed

123.

Haggiag S, Zhang PL, Slutzky G, Shinder V, Kumar A, Chebath J, et al. Stimulation of myelin gene expression in vitro and of sciatic nerve remyelination by interleukin-6 receptor-interleukin-6 chimera. J Neurosci Res. 2001;64(6):564–74.PubMed

124.

Zhang PL, Levy AM, Ben-Simchon L, Haggiag S, Chebath J, Revel M. Induction of neuronal and myelin-related gene expression by IL-6-receptor/IL-6: a study on embryonic dorsal root ganglia cells and isolated Schwann cells. Exp Neurol. 2007;208(2):285–96.PubMed

125.

Slutsky SG, Kamaraju AK, Levy AM, Chebath J, Revel M. Activation of myelin genes during transdifferentiation from melanoma to glial cell phenotype. J Biol Chem. 2003;278(11):8960–8.PubMed

126.

Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, et al. IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity. 2005;23(5):491–502.PubMed

127.

Yu S, Duan RS, Chen Z, Quezada HC, Bao L, Nennesmo I, et al. Increased susceptibility to experimental autoimmune neuritis after upregulation of the autoreactive T cell response to peripheral myelin antigen in apolipoprotein E-deficient mice. J Neuropathol Exp Neurol. 2004;63(2):120–8.PubMed

128.

Deretzi G, Pelidou S, Zou L, Quiding C, Mix E, Levi M, et al. Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6. Immunology. 1999;97(1):69–76.PubMedCentralPubMed

129.

Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M. Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord. 1996;6(2):105–14.PubMed

130.

Carlson CD, Hart RP. Activation of acidic sphingomyelinase and protein kinase C zeta is required for IL-1 induction of LIF mRNA in a Schwann cell line. Glia. 1996;18(1):49–58.PubMed

131.

Tofaris GK, Patterson PH, Jessen KR, Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci Off J Soc Neurosci. 2002;22(15):6696–703.

132.

Sugiura S, Lahav R, Han J, Kou SY, Banner LR, de Pablo F, et al. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci. 2000;12(2):457–66.PubMed

133.

Dowsing BJ, Romeo R, Morrison WA. Expression of leukemia inhibitory factor in human nerve following injury. J Neurotrauma. 2001;18(11):1279–87.PubMed

134.

Turka LA, Goodman RE, Rutkowski JL, Sima AA, Merry A, Mitra RS, et al. Interleukin 12: a potential link between nerve cells and the immune response in inflammatory disorders. Mol Med. 1995;1(6):690–9.PubMedCentralPubMed

135.

Zhu J, Bai XF, Mix E, Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin Immunol Immunopathol. 1997;84(1):85–94.PubMed

136.

Deng H, Yang X, Jin T, Wu J, Hu LS, Chang M, et al. The role of IL-12 and TNF-alpha in AIDP and AMAN. Eur J Neurol. 2008;15(10):1100–5.PubMed

137.

Pelidou SH, Deretzi G, Zou LP, Quiding C, Zhu J. Inflammation and severe demyelination in the peripheral nervous system induced by the intraneural injection of recombinant mouse interleukin-12. Scand J Immunol. 1999;50(1):39–44.PubMed

138.

Bonetti B, Valdo P, Stegagno C, Tanel R, Zanusso GL, Ramarli D, et al. Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. J Neuropathol Exp Neurol. 2000;59(1):74–84.PubMed

139.

Qin Y, Cheng C, Wang H, Shao X, Gao Y, Shen A. TNF-alpha as an autocrine mediator and its role in the activation of Schwann cells. Neurochem Res. 2008;33(6):1077–84.PubMed

140.

Taylor JM, Pollard JD. Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation. J Neuroimmunol. 2007;183(1–2):118–24.PubMed

141.

Constantin G, Piccio L, Bussini S, Pizzuti A, Scarpini E, Baron P, et al. Induction of adhesion molecules on human schwann cells by proinflammatory cytokines, an immunofluorescence study. J Neurol Sci. 1999;170(2):124–30.PubMed

142.

Sharief MK, McLean B, Thompson EJ. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barre syndrome. Ann Neurol. 1993;33(6):591–6.PubMed

143.

Sharief MK, Ingram DA, Swash M, Thompson EJ. I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome. Neurology. 1999;52(9):1833–8.PubMed

144.

Gold R, Zielasek J, Kiefer R, Toyka KV, Hartung HP. Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. Cell Immunol. 1996;168(1):69–77.PubMed

145.

Sawada T, Sano M, Omura T, Omura K, Hasegawa T, Funahashi S, et al. Spatiotemporal quantification of tumor necrosis factor-alpha and interleukin-10 after crush injury in rat sciatic nerve utilizing immunohistochemistry. Neurosci Lett. 2007;417(1):55–60.PubMed

146.

Be'eri H, Reichert F, Saada A, Rotshenker S. The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci. 1998;10(8):2707–13.PubMed

147.

Jander S, Pohl J, Gillen C, Stoll G. Differential expression of interleukin-10 mRNA in Wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res. 1996;43(2):254–9.PubMed

148.

Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, et al. Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000;97(19):10526–31.PubMedCentralPubMed

149.

Li X, Gonias SL, Campana WM. Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia. 2005;51(4):254–65.PubMed

150.

Keswani SC, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol. 2004;56(6):815–26. Epub 2004/10/08.PubMed

151.

Keswani SC, Leitz GJ, Hoke A. Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett. 2004;371(2–3):102–5.PubMed

152.

Keswani SC, Bosch-Marce M, Reed N, Fischer A, Semenza GL, Hoke A. Nitric oxide prevents axonal degeneration by inducing HIF-1-dependent expression of erythropoietin. Proc Natl Acad Sci U S A. 2011;108(12):4986–90.PubMedCentralPubMed

153.

Inoue G, Gaultier A, Li X, Mantuano E, Richardson G, Takahashi K, et al. Erythropoietin promotes Schwann cell migration and assembly of the provisional extracellular matrix by recruiting beta1 integrin to the cell surface. Glia. 2010;58(4):399–409.PubMedCentralPubMed

154.

Ahn M, Moon C, Jeong C, Matsumoto Y, Koh CS, Shin T. Upregulation of erythropoietin in rat peripheral nervous system with experimental autoimmune neuritis. Brain Res. 2010;1333:82–90.PubMed

155.

Luo B, Jiang M, Yang X, Zhang Z, Xiong J, Schluesener HJ, et al. Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis. Biochim Biophys Acta. 2013;1832(8):1260–70.PubMed

156.

Gorelik L, Constant S, Flavell RA. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med. 2002;195(11):1499–505.PubMedCentralPubMed

157.

Stoll G, Schroeter M, Jander S, Siebert H, Wollrath A, Kleinschnitz C, et al. Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages. Brain Pathol. 2004;14(1):51–8.PubMed

158.

D'Antonio M, Droggiti A, Feltri ML, Roes J, Wrabetz L, Mirsky R, et al. TGFbeta type II receptor signaling controls Schwann cell death and proliferation in developing nerves. J Neurosci Off J Soc Neurosci. 2006;26(33):8417–27.

159.

Blondet B, Carpentier G, Ferry A, Courty J. Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation. Neurochem Res. 2006;31(7):907–13.PubMed

160.

Blondet B, Carpentier G, Lafdil F, Courty J. Pleiotrophin cellular localization in nerve regeneration after peripheral nerve injury. J Histochem Cytochem. 2005;53(8):971–7.PubMed

161.

Mi R, Chen W, Hoke A. Pleiotrophin is a neurotrophic factor for spinal motor neurons. Proc Natl Acad Sci U S A. 2007;104(11):4664–9.PubMedCentralPubMed

162.

Göttle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, et al. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol. 2010;68(6):915–24.PubMed

163.

Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, et al. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta Neuropathol. 2012;124(6):847–60.PubMedCentralPubMed

164.

Toews AD, Barrett C, Morell P. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J Neurosci Res. 1998;53(2):260–7.PubMed

165.

Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, et al. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol. 2003;134(1–2):118–27.PubMed

166.

Fischer S, Weishaupt A, Troppmair J, Martini R. Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway. Glia. 2008;56(8):836–43.PubMed

167.

Groh J, Heinl K, Kohl B, Wessig C, Greeske J, Fischer S, et al. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X. Hum Mol Genet. 2010;19(18):3530–43.PubMed

168.

Kohl B, Fischer S, Groh J, Wessig C, Martini R. MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy. Am J Pathol. 2010;176(3):1390–9.PubMedCentralPubMed

169.

Taskinen HS, Roytta M. Increased expression of chemokines (MCP-1, MIP-1alpha, RANTES) after peripheral nerve transection. J Peripher Nerv Syst. 2000;5(2):75–81.PubMed

170.

Saika F, Kiguchi N, Kobayashi Y, Fukazawa Y, Kishioka S. CC-chemokine ligand 4/macrophage inflammatory protein-1beta participates in the induction of neuropathic pain after peripheral nerve injury. Eur J Pain. 2012;16(9):1271–80.PubMed

171.

Zou LP, Pelidou SH, Abbas N, Deretzi G, Mix E, Schaltzbeerg M, et al. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol. 1999;98(2):168–75.PubMed

172.

Kajii M, Kobayashi F, Kashihara J, Yuuki T, Kubo Y, Nakae T, et al. Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1alpha expression. J Neuroimmunol. 2014;266(1–2):43–8.PubMed

173.

Kim HJ, Jung CG, Jensen MA, Dukala D, Soliven B. Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy. J Immunol. 2008;181(12):8753–60.PubMedCentralPubMed

174.

Küry P, Greiner-Petter R, Cornely C, Jurgens T, Muller HW. Mammalian achaete scute homolog 2 is expressed in the adult sciatic nerve and regulates the expression of Krox24, Mob-1, CXCR4, and p57kip2 in Schwann cells. J Neurosci Off J Soc Neurosci. 2002;22(17):7586–95.

175.

Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, et al. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain J Neurol. 2002;125(Pt 4):823–34. Epub 2002/03/26.

176.

Press R, Pashenkov M, Jin JP, Link H. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol. 2003;23(4):259–67.PubMed

177.

Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Kury P, et al. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells. Neurobiol Dis. 2009;33(3):448–58. Epub 2008/12/30.PubMed

178.

Küry P, Koller H, Hamacher M, Cornely C, Hasse B, Muller HW. Cyclic AMP and tumor necrosis factor-alpha regulate CXCR4 gene expression in Schwann cells. Mol Cell Neurosci. 2003;24(1):1–9. Epub 2003/10/11.PubMed

179.

Ödemis V, Boosmann K, Heinen A, Küry P, Engele J. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J Cell Sci. 2010;123(Pt 7):1081–8. Epub 2010/03/04.PubMed

180.

Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR. TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci. 2006;31(3):407–15.PubMed

181.

Oliveira AL, Antunes SL, Teles RM, da Silva AC C, Silva TP, Brandao Teles R, et al. Schwann cells producing matrix metalloproteinases under Mycobacterium leprae stimulation may play a role in the outcome of leprous neuropathy. J Neuropathol Exp Neurol. 2010;69(1):27–39.PubMed

182.

Teles RM, Antunes SL, Jardim MR, Oliveira AL, Nery JA, Sales AM, et al. Expression of metalloproteinases (MMP-2, MMP-9, and TACE) and TNF-alpha in the nerves of leprosy patients. J Peripher Nerv Syst. 2007;12(3):195–204.PubMed

183.

Liu H, Shiryaev SA, Chernov AV, Kim Y, Shubayev I, Remacle AG, et al. Immunodominant fragments of myelin basic protein initiate T cell-dependent pain. J Neuroinflammation. 2012;9:119.PubMedCentralPubMed

184.

Kim Y, Remacle AG, Chernov AV, Liu H, Shubayev I, Lai C, et al. The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming Schwann cells in nerve regeneration. PLoS ONE. 2012;7(3):e33664.PubMedCentralPubMed

185.

Court FA, Zambroni D, Pavoni E, Colombelli C, Baragli C, Figlia G, et al. MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains. J Neurosci Off J Soc Neurosci. 2011;31(34):12208–17.

186.

Chen Y, Wang H, Yoon SO, Xu X, Hottiger MO, Svaren J, et al. HDAC-mediated deacetylation of NF-kappaB is critical for Schwann cell myelination. Nat Neurosci. 2011;14(4):437–41.PubMedCentralPubMed

187.

Limpert AS, Bai S, Narayan M, Wu J, Yoon SO, Carter BD, et al. NF-kappaB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci Off J Soc Neurosci. 2013;33(6):2388–97.

188.

Limpert AS, Carter BD. Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation. J Biol Chem. 2010;285(22):16614–22.PubMedCentralPubMed

189.

Nickols JC, Valentine W, Kanwal S, Carter BD. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci. 2003;6(2):161–7.PubMed

190.

Fu ES, Zhang YP, Sagen J, Candiotti KA, Morton PD, Liebl DJ, et al. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain. 2010;148(3):509–18.PubMedCentralPubMed

191.

Armstrong SJ, Wiberg M, Terenghi G, Kingham PJ. Laminin activates NF-kappaB in Schwann cells to enhance neurite outgrowth. Neurosci Lett. 2008;439(1):42–6.PubMed

192.

Sbai O, Devi TS, Melone MA, Feron F, Khrestchatisky M, Singh LP, et al. RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J Cell Sci. 2010;123(Pt 24):4332–9.PubMed

193.

Cheng C, Qin Y, Shao X, Wang H, Gao Y, Cheng M, et al. Induction of TNF-alpha by LPS in Schwann cell is regulated by MAPK activation signals. Cell Mol Neurobiol. 2007;27(7):909–21.PubMed

194.

Qin Y, Hua M, Duan Y, Gao Y, Shao X, Wang H, et al. TNF-alpha expression in Schwann cells is induced by LPS and NF-kappaB-dependent pathways. Neurochem Res. 2012;37(4):722–31.PubMed

195.

Pereira RM, Calegari-Silva TC, Hernandez MO, Saliba AM, Redner P, Pessolani MC, et al. Mycobacterium leprae induces NF-kappaB-dependent transcription repression in human Schwann cells. Biochem Biophys Res Commun. 2005;335(1):20–6.PubMed

196.

Laura M, Mazzeo A, Aguennouz M, Santoro M, Catania MA, Migliorato A, et al. Immunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritis. J Neuroimmunol. 2006;174(1–2):32–8.PubMed

Titel: Molecules Involved in the Crosstalk Between Immune- and Peripheral Nerve Schwann Cells
verfasst von: Nevena Tzekova
André Heinen
Patrick Küry
Publikationsdatum: 01.07.2014
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe Sonderheft 1/2014
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-014-0015-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 1/2014

Treatment of Multifocal Motor Neuropathy with Intravenous Immunoglobulin

Role of FcγRIIIA (CD16) in IVIg-Mediated Anti-Inflammatory Function

Fc Glycan-Modulated Immunoglobulin G Effector Functions

Intravenous Immunoglobulin (IVIG) Treatment Exerts Antioxidant and Neuropreservatory Effects in Preclinical Models of Alzheimer’s Disease

Immunomodulation and AD – Down But Not Out